Literature DB >> 22293629

Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay.

Alison M E Whitelegg1, Jane Birtwistle, Alex Richter, John P Campbell, James E Turner, Tarana M Ahmed, Lynda J Giles, Mark Fellows, Tim Plant, Alastair J Ferraro, Mark Cobbold, Mark T Drayson, Calman A MacLennan.   

Abstract

The measurement of antibody responses to vaccination is useful in the assessment of immune status in suspected immune deficiency. Previous reliance on enzyme-linked immunoabsorbent assays (ELISA) has been cumbersome, time-consuming and expensive. The availability of flow cytometry systems has led to the development of multiplexed assays enabling simultaneous measurement of antibodies to several antigens. We optimized a flow cytometric bead-based assay to measure IgG and IgM concentrations in serum to 19 antigens contained in groups of bacterial subunit vaccines: pneumococcal vaccines, meningococcal vaccines, Haemophilus influenzae b (Hib), and tetanus and diphtheria toxoid vaccines. 89-SF was employed as the standard serum. The assay was used to determine specific antibody levels in serum from 193 healthy adult donors. IgG and pneumococcal IgM antibody concentrations were measurable across 3 log10 ranges encompassing the threshold protective IgG antibody levels for each antigen. There was little interference between antibody measurements by the 19-plexed assay compared with monoplexed assays, and a lack of cross-reactive IgG antibody, but evidence for cross-reacting IgM antibody for 3/19 pneumococcal antigens. 90th centile values for 15/19 IgG concentrations and 12/12 IgM concentrations of the 193 adult sera were within these ranges and percentages of sera containing protective IgG antibody levels varied from 4% to 95% depending on antigen. This multiplexed assay can simultaneously measure antibody levels to 19 bacterial vaccine antigens. It is suitable for use in standard clinical practice to assess the in vivo immune response to test vaccinations and measure absolute antibody levels to these antigens. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293629     DOI: 10.1016/j.jim.2012.01.007

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Acute exercise enhancement of pneumococcal vaccination response: a randomised controlled trial of weaker and stronger immune response.

Authors:  Kate M Edwards; Meredith A Pung; Lianne M Tomfohr; Michael G Ziegler; John P Campbell; Mark T Drayson; Paul J Mills
Journal:  Vaccine       Date:  2012-08-22       Impact factor: 3.641

2.  Performance of a multiplexed serological microarray for the detection of antibodies against central nervous system pathogens.

Authors:  Anne J Jääskeläinen; Sari M Viitala; Satu Kurkela; Satu Hepojoki; Heidi Sillanpää; Hannimari Kallio-Kokko; Tomas Bergström; Jukka Suni; Ale Närvänen; Olli Vapalahti; Antti Vaheri
Journal:  J Microbiol Methods       Date:  2014-03-01       Impact factor: 2.363

3.  Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.

Authors:  Nadezhda A Wall; C Coral Dominguez-Medina; Sian E Faustini; Charlotte N Cook; Andrew McClean; Mark D Jesky; Marisol Perez-Toledo; Matthew D Morgan; Alexandra G Richter; Charles J Ferro; Paul Cockwell; Paul A Moss; Ian R Henderson; Lorraine Harper; Adam F Cunningham
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

4.  A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX).

Authors:  Ramin Mazhari; Jessica Brewster; Rich Fong; Caitlin Bourke; Zoe S J Liu; Eizo Takashima; Takafumi Tsuboi; Wai-Hong Tham; Matthias Harbers; Chetan Chitnis; Julie Healer; Maria Ome-Kaius; Jetsumon Sattabongkot; James Kazura; Leanne J Robinson; Christopher King; Ivo Mueller; Rhea J Longley
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

5.  Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.

Authors:  Jenny A Herbert; Emily J Kay; Sian E Faustini; Alex Richter; Sherif Abouelhadid; Jon Cuccui; Brendan Wren; Timothy J Mitchell
Journal:  Vaccine       Date:  2018-05-25       Impact factor: 3.641

6.  Subclinical Reactivation of Cytomegalovirus Drives CD4+CD28null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Dimitrios Chanouzas; Michael Sagmeister; Sian Faustini; Peter Nightingale; Alex Richter; Charles J Ferro; Matthew David Morgan; Paul Moss; Lorraine Harper
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

7.  Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management.

Authors:  Ilaria J Chicca; Jennifer L J Heaney; Gulnaz Iqbal; Janet A Dunn; Stella Bowcock; Guy Pratt; Kwee L Yong; Timothy D Planche; Alex Richter; Mark T Drayson
Journal:  Blood Cancer J       Date:  2020-11-04       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.